PMEA 2020 Accepting Entries
The PMEA Awards program is accepting entries for the 2020 event. The deadline for entries is Aug. 27. Set for [...]
Antonijevic Talks Adaptive Design Methods in Free On-Demand Webinar
Zoran Antonijevic, chair and leader of the DIA Adaptive Design Scientific Working Group, in an interview with Cytel discussed adaptive [...]
EMA Calls for Transparency, Collaboration in COVID-19 Studies
The European Medicines Agency (EMA) is urging transparency and collaboration on COVID-19 studies to facilitate more robust results. "High-quality observational [...]
Highlights of Flatiron Posters at ASCO Meeting
Flatiron Health in a recent post offers highlights of its eight posters on virtual display for the American Society of [...]
Inovalon Launches New Infection Surveillance, Reporting Solution
Inovalon has launched a new infection surveillance and reporting solution to help health care facilities in real-time map infections demonstrating [...]
Blues Plans in Lawsuit Claim CVS Inflated Generic Prices
Six insurers under the Blue Cross Blue Shield umbrella are suing CVS Health, claiming the pharmacy chain inflated generic drug [...]
ISPOR Offering Virtual Access to Short Courses
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering virtual access to its "most sought after" short courses. [...]
Virtual Series to Offer Insight into What’s in Store for Payers
An upcoming FierceHealthcare online virtual series will look at what payers can expect in the year ahead and beyond. "FierceHealthPayer [...]
Dubois: It’s Time to Talk COVID-19 Prices
In a race to develop a vaccine for COVID-19, the biopharmaceutical industry has worked at "unheard-of speed," National Pharmaceutical Council [...]
Study Examines Value-Based Arrangements
A study published earlier this year in Value in Health explores the role of value-based arrangements in the U.S. health [...]
AMCP to Host Webinar on Pre-Approval Communications with Payers
The Academy of Managed Care Pharmacy (AMCP) is set to host a webinar June 2 on how payers can fill [...]
COTA’s Narayanan Talks RWD in Interview with Aetion
COTA Healthcare's Life Sciences Vice President Viraj Narayanan in a recent interview with Aetion discussed how oncological real-world data can [...]
Study Finds Greater Risk of Death, Cardiac Problems Tied to Malaria Drugs Touted by Trump
A recent study suggests the malaria drugs touted by President Donald Trump as coronavirus treatments not only don't help, but [...]
JHE Editors Honor Wagstaff
The Journal of Health Economics is offering free access to the late Adam Wagstaff's contributions. Wagstaff had 24 full articles [...]
Shafrin: VBAs ‘Will Never Make Up a Majority of Reimbursement’
Healthcare economist Jason Shafrin says that while value-based agreements can be useful in a number of situations, they won't have [...]
Former FDA Chiefs Encourage Collection of RWE
Former Food and Drug Administration chiefs Mark McClellan and Scott Gottlieb urged greater incentives for the collection of real-world evidence [...]
Risks vs Rewards of Fast-Tracked Drug Evaluations
A recent article on Pharmacy Times outlines some of the risks and rewards of fast-tracking drug evaluations in the midst [...]
Haelle: More Studies Focusing on Quality of Life Needed
While an increasing number of studies are covering quality of life, there still are not enough, AHCJ's Tara Haelle writes. [...]
ICER Releases Draft Report on Ulcerative Colitis Therapies
The Institute for Clinical and Economic Review (ICER) recently released a draft evidence report on ulcerative colitis treatments. ICER is [...]
Research Finds Changes in Consumer Health Care Utilization
New research by Leede Research suggests roughly 72 percent of U.S. consumers have significantly changed their use of health care [...]
New Report Explores COVID-19 Implications for Pharma
A new FirstWord report explores how the COVID-19 could impact the pharmaceutical industry. The report, "COVID-19 implications for pharma: US [...]
Article Examines Coverage of Biosimilars
A recent article published in JAMA examines how commercial health plans cover biosimilars compared to their reference products. While Congress [...]
Study: No Confirmed Benefit of Hydroxychloroquine or Chloroquine in Treatment of COVID-19
Researchers in a recent study were unable to confirm any benefits of hydroxychloroquine or chloroquine in the treatment of COVID-19. [...]
Post Spotlights ICER’s Remdesivir Pricing Models
The authors of a recent Health Affairs blog post highlight the Institution for Clinical and Economic Review's (ICER) pricing recommendations [...]
A Look at Phlow CEO’s Track Record
STAT in a recent report takes a look at the track record of Phlow CEO Eric Edwards, who the Trump [...]